Health Care/Hospital APAC News & Press Release Distribution

Health Care/Hospital

All
Global

Triple Stimulus Voucher Mobile Payments Yield Astonishing Results--Kaohsiung New Yan Cheng Circle Revenues Double in 2nd Half of 2020

TAIPEI, July 7, 2021 /PRNewswire/ -- To respond to Taiwan's epidemic prevention measures and ease the challenges facing the shopping district due to the spread of COVID-19, Kaohsiung's New Yan Cheng Circle Prosperity Union introduced Triple Stimulus Voucher mobile payments in stores inJuly 2020, ...

2021-07-07 09:00 1393

Triple Stimulus Voucher Mobile Payments Yield Astonishing Results--Kaohsiung New Yan Cheng Circle Revenues Double in 2nd Half of 2020

CStone announces China NMPA acceptance of IND application for CS2006/NM21-1480, a PD-L1/4-1BB/HSA multi-specific antibody-based molecule, marking further expansion of its Pipeline 2.0 strategy

SUZHOU, China, July 7, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on the research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the investigational new ...

2021-07-07 08:05 2414

New Cancer Treatment For Australian Dogs With APVMA Approval Of Qbiotics' Stelfonta®

* STELFONTA® (tigilanol tiglate) is now approved by the Australian Pesticides and Veterinary Medicines Authority (APVMA) for the treatment of canine non-metastatic mast cell tumours (MCT). * APVMA approval follows marketing authorisation (registration) and launch of STELFONTA® in the major co...

2021-07-07 06:34 1562

New Cancer Treatment For Australian Dogs With APVMA Approval Of Qbiotics' Stelfonta®

LBB Specialties Enters Agreement with Leading Innovative Actives Manufacturer GREAF

NORWALK, Conn., July 7, 2021 /PRNewswire/ -- LBB Specialties (LBBS), a leader in North American specialty chemicals and ingredients distribution, announced it has entered a contractual agreement withGREAF, the global supplier of responsibly sourced, plant-derived novel active ingredients. The agr...

2021-07-07 01:45 1689

Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins EpiVax

PROVIDENCE, R.I., July 7, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce that Dr.Amy Rosenberg is leaving the FDA's Division of Therapeutic Proteins, CDER, which she led for over 20 years, to join EpiVax as Senior Director of Immunology and Protein Therapeutics. Dr. Rosenber...

2021-07-07 01:43 1919

Transcenta Announces NMPA Acceptance of IND Application of its Anti-Sclerostin Monoclonal Antibody TST002

SUZHOU, China, July 6, 2021 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announces that NMPA has accepted IND applica...

2021-07-06 21:36 1454

RamSoft Acquires a Majority Stake in Meddiff to Advance Patient Care Globally

TORONTO, July 6, 2021 /PRNewswire/ -- RamSoft, a leading healthcare IT software and services company, today announced it has taken a majority stake in Meddiff Technologies, an innovative medical imaging solutions company. This acquisition will accelerate RamSoft's product development by combining...

2021-07-06 21:00 1421

Bon Natural Life Limited Announces Land Acquisition to Construct Its Third Production Facility

XIAN, China, July 6, 2021 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solutions provider in the natural, health and personal care industries, today announced that they have received the certificate of a land use right for the future si...

2021-07-06 21:00 3669

Seegene announces partnership with Bio-Rad to develop diagnostic testing products for the U.S. Market

* Seegene announces partnership with Bio-Rad for the development and commercialization of infectious disease molecular diagnostic products * Diagnostic tests designed for the pandemic and the post-pandemic era with high multiplex technology * A significant step forward for Seegene in expandi...

2021-07-06 18:00 1612

PolyU develops highly sensitive, microscopic optical fibre sensors with pioneering biomedical monitoring capability

HONG KONG, July 6, 2021 /PRNewswire/ -- The Hong Kong Polytechnic University (PolyU) has made a breakthrough development in optical fibre sensors, making the advanced railway safety monitoring technologies available for medical surveillance inside the human body. The research team led by Profess...

2021-07-06 17:06 1327

Inbiose applies for FDA GRAS approval of four new Human Milk Oligosaccharides

GHENT, Belgium, July 6, 2021 /PRNewswire/ -- Inbiose, a leading biotech company active in the development of Human Milk Oligosaccharides (HMOs), is pleased to announce that it has submitted its application for a Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FD...

2021-07-06 15:00 1687

Inbiose applies for FDA GRAS approval of four new Human Milk Oligosaccharides

Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate

* SPECTRA enrolled over 29,000 adult and elderly participants across four continents achieving high ethnic diversity and robust dataset of circulating strains * Release of vaccine efficacy data anticipated in Q3 2021 and will include sequencing data of SARS-CoV-2 variants of concern and varia...

2021-07-06 14:00 2137

Bora Group announce the rebranding of Yuta Health to Bora Health

TAIPEI, July 6, 2021 /PRNewswire/ -- Leading Taiwan-based contract development and manufacturing organization (CDMO) Bora Group today announced a name change for its subsidiary, currently Yuta Health, to Bora Health Inc. as part of an overall plan to integrate its distribution operations and b...

2021-07-06 13:31 2074

Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China

SAN FRANCISCO and SUZHOU, China, July 6, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major disease...

2021-07-06 08:00 3542

Antengene Announces Acceptance of IND Application in China for the Phase II Clinical Trial of Single-Agent Selinexor for the Treatment of Myelofibrosis (MF)

SHANGHAI and HONG KONG, July 6, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-07-06 08:00 2679

South-Korean biotech Y-Biologics and French mid-pharma Pierre Fabre enter into a worldwide exclusive license agreement in the highly innovative field of immuno-oncology

DAEJEON, South Korea and CASTRES, France, July 6, 2021 /PRNewswire/ -- The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have entered into a license agreement granting worldwide exclusive rights toPierre Fabre to develop and commercialize a family of hum...

2021-07-06 07:00 2103

SINOMED announces a clinical collaboration with the National University of Ireland Galway to evaluate a non-invasive assessment method for stenting

TIANJIN, China, July 5, 2021 /PRNewswire/ -- SINOMED, a leading international medical device company, today announced that they have teamed up with the National University of Ireland Galway (NUI Galway) to conduct a clinical trial for a new assessment method for stenting. The trial will employ the...

2021-07-05 19:42 2236

SINOMED announces a clinical collaboration with the National University of Ireland Galway to evaluate a non-invasive assessment method for stenting

Octapharma's ongoing dedication to improving the lives of people with haemophilia and von Willebrand disease to be showcased at the ISTH 2021 Congress

LACHEN, Switzerland, July 5, 2021 /PRNewswire/ -- Octapharma announced today that new clinical and scientific findings encompassing their Haematology portfolio, including Nuwiq®, wilate®, octanate® and octanine®F, will be presented at the upcoming International Society on Thrombosis and Haemostas...

2021-07-05 19:30 2057

Everest Medicines Announces that Spero Therapeutics Entered into Licensing Agreement with Pfizer Inc. for SPR206 in ex-U.S. and ex-Asia Territories

SHANGHAI, July 5, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients inGreater China and other parts ofAsia, today announce...

2021-07-05 18:16 2690

Reckitt and Shopee support Vietnamese in fight against pandemic with 'Protection Starts From Within' campaign

HO CHI MINH CITY, Vietnam, July 5, 2021 /PRNewswire/ -- Reckitt, the global leader in health, hygiene and nutrition, partners with Shopee, the leading e-commerce platform inSoutheast Asia and Taiwan to launch its first "Protection Starts From Within" regional initiative held across six markets. T...

2021-07-05 14:45 2794

Reckitt and Shopee support Vietnamese in fight against pandemic with 'Protection Starts From Within' campaign

1 ... 312 313 314315316 317 318 ... 553